Get started
Author

Sam Harris

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
2022 · Jeanne Tie, Joshua D. Cohen, et al. · New England Journal of Medicine · 1,178
PDF
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
2025 · Jeanne Tie, Yuxuan Wang, et al. · Nature Medicine · 118
Risk-Directed Ambulatory Thromboprophylaxis in Lung and Gastrointestinal Cancers: The TARGET-TP Randomized Clinical Trial
2023 · Marliese Alexander, Sam Harris, et al. · JAMA Oncology · 36
PDF
Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
2013 · Mun Sem Liew, Joseph Sia, et al. · Cancer Medicine · 33
PDF
COVID‐19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study
2022 · Mike Nguyen, Nathan Bain, et al. · Asia-Pacific Journal of Clinical Oncology · 30
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia
2022 · Daphne Day, Lisa Grech, et al. · Vaccines · 28
PDF
Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation
2012 · M C Di Bernardo, P Broderick, et al. · Leukemia · 16
318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC)
2022 · J. Tie, J. Cohen, et al. · Annals of Oncology · 15
Pharmacogenetic‐guided dosing for fluoropyrimidine ( DPYD ) and irinotecan ( UGT1A1*28 ) chemotherapies for patients with cancer ( PACIFIC ‐ PGx ): A multicenter clinical trial
2024 · Sarah Glewis, Senthil Lingaratnam, et al. · Clinical and Translational Science · 12
PDF
Patient and healthcare professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: A cross sectional survey
2023 · Sarah Glewis, Mei Krishnasamy, et al. · Clinical and Translational Science · 9
PDF
COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers
2022 · Nathan Bain, Mike Nguyen, et al. · Vaccines · 9
PDF
Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials
2015 · Juanita Lopez, Sam Harris, et al. · Translational Oncogenomics · 9
PDF
Pharmacogenomics guided dosing for fluoropyrimidine and irinotecan chemotherapies for patients with cancer (PACIFIC-PGx): study protocol of a multicentre clinical trial
2022 · Sarah Glewis, Marliese Alexander, et al. · Acta Oncologica · 8
PDF
Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial
2023 · Marliese Alexander, Ian Collins, et al. · Internal Medicine Journal · 7
PDF
Implementing Teletrials to Improve Equity of Access for Regional Patients With Cancer: Report From the Victorian Teletrial Collaborative
2025 · Craig Underhill, A. Woollett, et al. · Asia-Pacific Journal of Clinical Oncology · 5
PDF
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial
2026 · Adnan Nagrial, Matteo S. Carlino, et al. · Clinical Cancer Research · 4
Teletrial implementation in early phase clinical trials: two national workshops
2025 · Jessica Freeman, Craig Underhill, et al. · Trials · 3
PDF
Cost-Effectiveness of Pre-emptive DPYD Genotyping Compared to Standard of Care Among Patients Receiving Fluoropyrimidine-Based Anti-cancer Treatment in Australia
2025 · Sarah Glewis, Mussab Fagery, et al. · Clinical Drug Investigation · 2
PDF
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers
2025 · Marliese Alexander, Chiao Xin Lim, et al. · Clinical and Translational Science · 2
PDF
882TiP Subcutaneous vs intravenous nivolumab in patients with melanoma following complete resection
2022 · P.A. Ascierto, P. Mohr, et al. · Annals of Oncology · 2
Artificial Intelligence-Assisted Risk Stratification in Stage II Colorectal Cancer: Multi-Institutional Validation of Semantically Enhanced Deep Learning
2026 · Francis Magisson, Zhen He, et al. · Gastroenterology · 1
PDF
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
2024 · Richard Blennerhassett, Nada Hamad, et al. · Acta Haematologica · 1
PDF
376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
2023 · Ribhu Nayar, Shazad A Khokhar, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Poster Abstracts
2021 · Harris, Sam, Chau, Hieu, et al. · Asia-Pacific Journal of Clinical Oncology · 1
PDF
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage II Colon Cancer (DYNAMIC Trial): Statistical Analysis Plan
2021 · Jeanne Tie, Serigne N. Lo, et al. · medRxiv · 1
PDF
Works count: 32
Citation count: 1,531
H-index: 9
I10-index: 9
Year
Topic
Type